Curis | CRIS - Debt


Curis reported $0 in Debt for its fiscal quarter ending in June of 2022.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Amgen USD 57.32B 2.72B Mar/2026
AstraZeneca USD 32.24B 1.68B Jun/2026
Bayer EUR 36.45B 2.93B Dec/2025
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
CSL USD 11.96B 219M Dec/2024
Curis USD 0 0 Jun/2022
Eli Lilly USD 43.37B 867M Mar/2026
Exelixis USD 165.93M 3.61M Jun/2026
Gilead Sciences USD 22.17B 2.76B Mar/2026
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
Incyte USD 38.27M 1.16M Jun/2026
Merck USD 49.12B 222M Mar/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 63.19B 536M Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026
Takeda JPY 4.94T 58.13B Jun/2026
TG Therapeutics USD 754.44M 884K Jun/2026
Verastem USD 66.79M 26.7M Sep/2024